Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839096 · ClinicalTrials.gov registry record · NA
Once Versus Twice Daily Iron Supplementation in Pregnant Women
A NA study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02839096 is a NA study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 20 participants.
The verdict
NCT02839096, a NA study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation
Interventions
- DRUG Placebo
- DRUG Ferrous Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-06 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02839096
The ClinicalTrials.gov registry entry for NCT02839096 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02839096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02839096 about?
NCT02839096 is a clinical study titled "Once Versus Twice Daily Iron Supplementation in Pregnant Women". The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation
What is the current status of trial NCT02839096?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2016-06. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02839096?
The interventions under investigation include: Placebo (DRUG), Ferrous Sulfate (DRUG).
Who is sponsoring clinical trial NCT02839096?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.